Imeglimin
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Imeglimin, covering 2015-08-13 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus [Phase 4]